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1. Introduction 
The lignans are a class of compound with a diben- 
zylbutane skeleton [l] and which until recently had 
only been found in higher plants [2]. The first lignans 
to be identified in humans and monkeys were described 
in [3,4], their structures differing from all known 
plant lignans in having me&substitution in the benzyl 
groups. The two principal lignans identified were 
2,3-bis(3’-hydroxybenzyl)butyrolactone (HBBL) and 
2,3&(3’hydroxybenzyl)-butane-1,4diol (HBBD) 
and their structures are shown in fig.1. The quantita- 
tive excretion of HBBL and HBBD was found to 
exhibit a cyclic pattern during the menstrual cycle of 
humans [3-61 and monkeys [7], maximum excretion 
occurring in the luteal phase and elevated levels were 
found in urine collected during early pregnancy [6]. 
Circumstantial data suggested lignans were possibly of 
ovarian origin or their production was modulated by 
ovarian function [3]. HBBL was also identified in 
human pregnancy and suggested to be of ovarian source 






Fig.1. Chemical formulae of the principal mammalian lignans: 
(I) 2,3&s-(3’-hydroxybenzyl)+utyrolactone; (II) 2,3&s- 
(3’-hydroxybenzyl)-butane-1,4diol. 
To facilitate studies on the biosynthesis and metab- 
olism of lignans, a search was made for an inexpensive 
and convenient laboratory animal. Here we report on 
the excretion of lignans in the urine and bile of rats, 
demonstrate that they are formed by intestinal bac- 
teria and confirm an enterohepatic circulation. 
2. Experimental 
2 .l . Animal experiments 
Rats were placed in restraining cages with free access 
to water or saline and food pellets. Bile and urine were 
collected for 1 week at 12-24 h intervals from con- 
ventional adult male and female rats (-200 g) of the 
Sprague-Dawley strain. Bile fistula were inserted into 
rats by conventional procedures and collections of bile 
commenced from the day of operation. A number of 
rats, with and without bile fistula, were ovariectomised 
and collections of bile and/or urine started 1 week 
after the operation. Urine was collected over a 1 week 
period from 3 adult male rats of the Long-Evans strain, 
reared germ-free as in [9] and placed in metabolism 
cages with free access to water and a sterilized diet. 
Urine collected from 3 adult male rats of the same 
stock, reared outside the germ-free isolators, on the 
same diet, were used as controls. Collections (12 h) 
were made from 3 adult female germ-free rats of the 
Sprague-Dawley strain. 
Blood samples were obtained from the inferior 
vena cava and the portal vein of female Sprague- 
Dawley rats, transferred to heparinised tubes and 
centrifuged immediately. The plasma was separated 
and stored at -20°C until analysed. 
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2.2. Analy tical procedure 3. Results and discussion 
2.2 .I . Total lignans 3 .I . Identification of lignans in urine and bile from 
Lignans and their conjugates were extracted from 
urine using SepPak(Cra) cartridges essentially as 
described for steroids [lo]. Lignan conjugates were 
hydrolysed by Helix pomatia digestive juice (a mixed 
/I-glucuronidase and sulphatase preparation) and the 
deconjugated lignans were extracted from the hydrol- 
ysate using SepPak (Crs) cartridges. The extracts 
were then filtered through small columns of a cation 
exchange gel, SP-Sephadex-LH-20 [H’] packed in 
methanol and then purified on small columns of a 
strong anion exchange gel, triethylaminohydroxy- 
propyl Sephadex LH-20 (TEAP-LH-20) in the OH- 
form. Neutral compounds were eluted with methanol 
and methanol/chloroform (1: 1, v/v) prior to the selec- 
tive elution of phenolic compounds with methanol 
saturated with COZ [ 111. Lignans were analysed by 
gas chromatography (CC) and gas chromatography- 
mass spectrometry (CC-MS) as their trimethylsilyl 
(TMS) ether derivatives [6]. 
conventional rats 
2.2.2. Analysis of individual lignan conjugates in 
urine, bile and plasma 
This was done by the procedures in [ 11 ,I 21. After 
extraction, lignans were separated according to their 
mode of conjugation, into unconjugated phenolic 
compounds, glucuronides, monosulphate and disul- 
phate conjugates on small columns of the anion 
exchange gel TEAP-LH-20. Lignan glucuronides were 
hydrolysed enzymatically and the sulphates solvol- 
ysed, before purification on small columns of TEAP- 
LH-20 [12]. 
Two lignans, isolated from the urine and bile of 
conventional rats were identified definitively as 
2,3-bis-(3’-hydroxybenzyl)-butyrolactone(HBBL)and 
2,3&s-(3’-hydroxybenzyl)butane-1,4-diol (HBBD) 
on the basis of GC retention times (tR = 27.50 MU 
and tR = 27.70 MU, respectively for the TMS ethers 
fig.2) complete mass spectra and partial mass spectra 
obtained from fragment ion current (FIC) chromato- 
grams constructed of characteristic ions given by lignan 
derivatives (fig.3). These two lignans are identical to 
the lignans found in the urine of humans [3,4,8] and 
vervet monkeys [7]. A phenolic compound (referred 
here as 386/192 tR = 27.3 MU) of apparently related 
structure was found in all samples in greater amounts 
than both of the identified lignans (fig.2,3). The mass 
spectrum of the TMS ether of this compound is shown 
in fig.4 and indicates a molecular ion at m/z 386. The 
fragment m/z 207 is formed by the loss of 179 mass 
units from the molecular ion, due to cleavage of a 
benzylic group containing a trimethylsiloxy function. 
a characteristic fragmentation seen in the mass spectra 
of HBBL and HBBD [3,4]. The most prominent ion 
2.3. GC and GC-MS analysis 
Following addition of an internal standard 3a- 
hydroxy-So-cholestane, the lignans were converted to 
TMS ether derivatives and analysed by capillary col- 
umn CC-MS [ 11 ,121. Quantification was performed 
by GC on open-tubular glass capillary columns coated 
with SE-30 and using flame ionisation detection [ 121. 
Due to the low concentration of lignans in the sulphate 
fractions and in plasma, quantification was carried 
out using a selective ion monitoring GC-MS procedure 
as in [12]. 
Ic. 




Fig.2. A typical isothermal gas chromatographic recording of 
the TMS ether derivatives of the compounds present in a 
phenolic glucuronide fraction from the urine of a female rat. 
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Fig.3. CC-MS analysis of lignans in the phenolic glucuronide 
fraction from the urine of a normal female rat. FIC chromato- 
grams constructed by the computer are shown for the ions 
characteristic of TMS ethers of the unidentified compound 
386/192 (m/z 192,386 and 371), HBBD (m/z 180,500,410 
and 231) and HBBL (m/z 180,442,427 and 263). 
and base peak in the spectrum, m/z 192, differs from 
the base peak in the TMS ethers of the lignans, (m/z 
180). In view of the phenolic nature of this com- 
pound, this ion may arise from a fragment consisting 
of (CHs)$i-0-C6H4--CHCH2, but this remains to 
be established. This ion is however known to be pro- 
duced by certain phenolic compounds [ 131. The pres- 
ence of two reactive hydroxyl groups was established 
from analysis of the mass spectrum of the deuterium 
labelled TMS ether derivative. When chromatographed 
on the weak anion exchanger DEAE-Sephadex, this 
compound was eluted in the fraction corresponding 
to diphenolic compounds, confirming the two deriva- 
tisable hydroxyl functions to be aromatic. As the mol. 
wt of this compound is 386 (as the his-TMS ether 
derivative) its structure must differ from the lignans 
HBBL and HBBD in not having the basic dibenzylbu- 
tane skeleton.Compound 386/l 92 has also been found 
in small quantitiesin the urine of humans,and further 
work is ongoing to establish the structure of this com- 
pound. 
3.2. Quantitative excre tion of lignans in urineand bile 
3.2 .l . Conjugation 
The diphenolic compounds described above were 
excreted in urine and bile almost exclusively as acidic 
conjugates. These conjugates were identified as glucu- 
ronides and sulphates from their mobilities on the ion 
exchange gel TEAP-LH-20 and because they could be 
hydrolysed by fl-ghrcuronidase nzymes and by a mild 
solvolytical procedure, respectively [ 121. HBBL and 
HBBD have previously been definitively identified in 
human urine as intact glucuronides using CC-MS and 
quantitatively are excreted in urine almost exclusively 
in this form [ 121. 
In rat urine the distribution of the lignans HBBL 
and HBBD within the conjugate classes (table 1) was 
similar to the human. One difference from the human 
and monkey, is the higher proportion of sulphate 
conjugates present in rat urine, however rats have a 
high level of sulphokinase activity in the liver [ 141. 
Although not yet proven, it was suggested that this 
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Fig.4. Mass spectrum of the TMS ether derivative of the unknown diphenolic compound 386/192, isolated from rat urine. 
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Table 1 
Distribution (%) of conJugates of the lignans 2,3&s-(3’-hydroxybenzyl)-butyrolactone (HBBL), 2,3-his-(3’-hydroxybenzyl) 

























HBBL HBBD 3861192 
21.2 5.8 0.2 
6.3 2.9 0.1 
0.1 0.1 0.2 
conjugation most probably occurs in the liver [ 121. In 
rat bile all 3 compounds were identified as glucuronide 
conjugates (table 1) and only traces of sulphates 
(<l%) were found. The unknown diphenolic com- 
pound differed from the 2 lignans in being present 
exclusively as a glucuronide conjugate in both urine 
and bile 099 S%). 
3.2.2. Conventional rats 
All 3 diphenolic compounds were excreted in urine 
and bile in relatively large amounts by normal rats. 
On a body weight basis the daily urinary excretion of 
the lignans HBBL and HBBD considerably exceeded 
(5-20-fold) the amounts found in humans [3,5,6] 
and there was some evidence to indicate a sex differ- 
ence in the excretion of these compounds; female rats 
excreting larger amounts of HBBL and smaller amounts 
of the unknown diphenolic compound compared with 
male animals. Such differences are not uncommon in 
rats, steroid metabolism is characterised by qualitative 
differences between the male and female [ 151, how- 
ever, in view of the limited number of measurements, 
additional data are required to confirm this observa- 
tion. In all cases, the quantitative urinary excretion of 
the unknown diphenolic compound was always greater 
than the lignans HBBL and HBBD and its behaviour 
was found to parallel that of the 2 lignans. 
Earlier studies in the human suggested the ovaries 
as a possible source oflignans [3,6,8]. This hypothesis 
was tested by measuring the excretion of lignans 
before and after the removal of the ovaries from nor- 
mal rats. No significant difference between the urinary 
excretion of these compounds before and 7 days after 
ovariectomy was found (table 2). 
Table 2 
Total excretion &g/24 h) of the lignans 2,3-his-(3’hydroxybenzyl)-butyrolactone 
(HBBL) and 2,3&s-(3’-hydroxybenzyl)butane-1,4diol (HBBD) and the unknown 












Female Bile drainage 
Female Bile drainage 
Female Ovariectomized 
Total excretion &g/24 h) 
HBBL HBBD 3861192 
4.0 1.0 128.6 
21.2 1.5 50.0 
6.0 0.4 12.0 
14.0 0.4 60.4 
20.2 0.8 46.8 
[ Urine Female Ovariectomized+ I bile drainage 
Bile Female Ovariectomized + 
bile drainage 
10.3 0.4 18.2 
11.0 0.3 57.2 
Urine Male Germ-free <O.l <O.l <O.l 
Urine Female Germ-free <O.l <O.l <O.l 
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Table 3 
Concentrations (ng/ml plasma) of 2,3-his-(3’-hydroxybenzyl)-butyrolactone 




Conditions HBBL 3861192 
Free Glucuronide Free Glucuronjde 
v. cava inf. Normal 1.1 3.9 3.9 63.0 
v. porta Normal 2.8 56.0 23.6 351.0 
v. porta Bile drainagea 1.3 1.6 I .4 5.4 
a Blood collected 2 days after insertion of a bile fist& 
HBBL, HBBD and compound 386/192 were iden- 
tified in high concentrations in rat bile. When bile 
fistula were inserted in female rats and the bile drained, 
the daily urinary excretion of all three compounds 
decreased significantly (table 2). The quantitative 
excretion of HBBL and the unknown compound in 
bile during this period was 2%S-fold greater than in 
the corresponding urine samples, while the combined 
excretion of these compounds in urine and bile was 
similar to the urinary excretion by intact conventional 
rats. All of this evidence indicates that an entero- 
hepatic circulation exists whichis further substantiated 
by measurements of the concentrations of HBBL and 
compound 386/192 in samples of plasma collected 
from the portal vein (table 3). Concentrations of con- 
jugated HBBL (56 ng/ml) and compound 386/192 
(35 1 ng/ml) in plasma were very much higher than in 
the inferior vena cava (3 9 ng/mland 63 ng/ml, respec- 
tively , for both compounds). 
In the portal vein, these compounds were present 
principally as glucuronide conjugates which indicates 
that they are efficiently re-absorbed from the gut as 
conjugates. As would be expected, in response to 
interruption of the enterohepatic circulation, the con- 
centrations of conjugated HBBL and compound 386/ 
192 in the portal vein were reduced dramatically on 
biliary drainage. 
3.2.3. Germ-free rats 
The highly aromatic nature and unusual structure 
of the lignans together with optical rotation measure- 
ments showing their occurrence as racemic compounds 
[4,8] was an early indication that these compounds 
could be formed by intestinal microflora. To confirm 
this hypothesis urine was collected from male and 
female rats, reared germ-free [9]. Lignan excretion 
under these conditions was undetectable (<O.l pg/ 
day) as was the excretion of the unknown diphenolic 
compound, thereby confirm,mg a bacterial origin for 
the production of this new class of compounds. 
The formation of lignans in the intestine was sup- 
ported by the observation that biliary drainage resulted 
in little change in the blood levels of unconjugated 
lignans whereas levels of lignan glucuronides decreased 
dramatically in the portal vein (table 3). The uncon- 
jugated compounds therefore must represent newly 
formed phenolic compounds in the intestine which 
are returned to the liver for conjugation to glucuronic 
acid before being excreted in the bile. These results 
also indicate that there occurs an efficient reabsorption 
of the glucuronide conjugates from the intestine. 
4. Conclusions 
The data presented indicate the rat to be a conve- 
nient animal model for the study of lignans, a new 
group of compounds recently identified in humans, 
In addition to the previously identified lignans, 
2,3-bis-(3’-hydroxybenzyl)-butyrolactone(HBBL)and 
2,3-his-(3’hydroxybenzyl)-butane-1,4diol (HBBD) a 
compound of an as yet unidentified structure is quan- 
titatively the major diphenolic compound excreted 
by rats and its physiological behaviour was found to 
parallel that of the lignans. 
The observations of a cyclic pattern of excretion 
of HBBL and HBBD during the menstrual cycle of 
humans [3,5,6 81 and monkeys [ 71 suggested initially 
that they were produced by the ovaries or influenced 
by ovarian function. Using the rat however, we have 
unequivocally demonstrated that lignans are not 
formed in the ovaries but are biosynthesised by intes- 
tinal bacteria, resembling therefore vitamin K syn- 
thesis. Studies using selective antibiotic therapy in 
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humans have also confirmed a bacterial source for the 
production of lignans [ 16 1. An enterohepatic circula- 
tion of lignans occurs; they are absorbed from the 
intestine, transferred to the liver and conjugated, 
excreted in bile and reabsorbed mainly as conjugates. 
Their physiological behaviour resembles cholesterol 
[1720],bile acids [21] bile pigments [22],oestrogens 
[23,24],vitamin Blz [25] andfolicacid [26,27],com- 
pounds which also have an enterohepatic circulation. 
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Note added in proof 
Using CC-MS and NMR spectrometry the unknown 
compound 386/192 described has been identified as 
equol (Axelson, M., Kirk, D. N., Lawson, A. M. and 
Setchell, K. D. R., in preparation), a compound first 
isolated from pregnant mare’s urine by G. F. Marrian 
and G. A. D. Haselwood (Biochem. J. (1932) 26, 
1227) and later shown to possess weak oestrogenic 
activity (Schutt, D. A. and Brayden, A. W. (1968) 
Aust.J.Agric.Res. 19,545). 
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